Source: Canfite Can-Fite BioPharma Ltd. announced positive results from a multicenter clinical study conducted by its Veterinary partner Vetbiolix, evaluating Piclidenoson for treating canine osteoarthritis. The study demonstrated that oral administration of Piclidenoson (500 µg/kg twice daily) significantly improved mobility, reduced pain, and alleviated symptoms as assessed through the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire, […]
read morePositive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix
by Editor | Dec 10, 2024 | Animal Health Industry, Animal Health News
